GoHealth, Inc. (NASDAQ:GOCO) Short Interest Update

GoHealth, Inc. (NASDAQ:GOCO) saw a large growth in short interest in the month of June. As of June 15th, there was short interest totaling 1,052,454 shares, a growth of 129.2% from the May 31st total of 459,241 shares. Based on an average trading volume of 1,461,180 shares, the short-interest ratio is presently 0.7 days. Approximately 5.1% of the company’s stock are sold short.

GoHealth Trading Down 2.3%

NASDAQ GOCO traded down $0.01 during mid-day trading on Tuesday, hitting $0.30. The company’s stock had a trading volume of 2,704,303 shares, compared to its average volume of 916,731. The firm has a market capitalization of $8.60 million, a price-to-earnings ratio of -0.01 and a beta of 1.19. The company’s 50 day simple moving average is $0.71 and its 200 day simple moving average is $1.50. GoHealth has a twelve month low of $0.28 and a twelve month high of $7.12.

GoHealth (NASDAQ:GOCO) last released its quarterly earnings data on Monday, May 18th. The company reported ($2.36) earnings per share for the quarter, beating analysts’ consensus estimates of ($2.40) by $0.04. The firm had revenue of $11.91 million for the quarter, compared to analyst estimates of $16.90 million. GoHealth had a negative net margin of 189.73% and a negative return on equity of 402.70%. As a group, research analysts forecast that GoHealth will post -9.19 EPS for the current year.

Analyst Ratings Changes

Several equities research analysts have weighed in on GOCO shares. Noble Financial raised shares of GoHealth to a “strong-buy” rating in a research note on Wednesday, April 1st. Weiss Ratings restated a “sell (e+)” rating on shares of GoHealth in a research note on Friday, April 24th. Finally, Freedom Capital lowered GoHealth from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 6th. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, GoHealth currently has an average rating of “Hold” and an average price target of $5.00.

Institutional Trading of GoHealth

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Redwood Capital Management LLC purchased a new stake in shares of GoHealth in the third quarter worth approximately $4,455,000. Geode Capital Management LLC boosted its position in shares of GoHealth by 8.1% during the fourth quarter. Geode Capital Management LLC now owns 150,821 shares of the company’s stock valued at $324,000 after buying an additional 11,340 shares during the last quarter. Corient Private Wealth LLC grew its holdings in GoHealth by 7.7% during the second quarter. Corient Private Wealth LLC now owns 125,938 shares of the company’s stock worth $699,000 after buying an additional 8,979 shares in the last quarter. Barclays PLC grew its holdings in GoHealth by 10.1% during the fourth quarter. Barclays PLC now owns 81,181 shares of the company’s stock worth $175,000 after buying an additional 7,430 shares in the last quarter. Finally, Focus Partners Wealth purchased a new stake in GoHealth in the 3rd quarter valued at $270,000. 24.21% of the stock is owned by institutional investors.

About GoHealth

GoHealth, Inc is a technology-driven health insurance marketplace that connects consumers with a wide range of health insurance plans from leading carriers. Through its digital platform, the company facilitates the comparison, selection and enrollment process for individual and family plans, as well as Medicare Advantage and Medicare Supplement products. By leveraging data analytics and customer support services, GoHealth aims to simplify a traditionally complex market and enable more informed decision-making for policyholders.

The company’s online portal integrates real-time quoting tools, educational resources and access to licensed insurance agents, ensuring that users receive personalized guidance throughout the enrollment journey.